TuHURA Biosciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +146.8% | +24.5% | -10.6% | -42.9% | -27.2% | +361.0% | -52.7% | +137.4% | -71.3% | +357.8% | +37.0% | |
| – | +212.0% | +24.5% | -10.5% | -42.9% | -31.5% | +327.7% | -51.8% | +159.5% | -71.8% | +371.5% | -76.4% | |
| – | +251.0% | +7.0% | -9.3% | -37.7% | -35.7% | +340.5% | -47.4% | +157.0% | -74.3% | +245.3% | -71.4% | |
| – | +251.0% | +7.0% | -9.3% | -37.7% | -35.7% | +340.5% | -47.4% | +157.0% | -74.3% | +245.3% | -71.4% | |
| – | -28.8% | +316.6% | -48.4% | -33.7% | – | – | – | – | +229.7% | -33.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +11.9% | -29.5% | -57.5% | – | – | – | – | – | – | – | |
| – | -55.9% | -11.0% | +23.0% | +26.2% | +29.2% | +10.7% | +141.4% | -59.5% | +104.7% | -9.3% | +19.5% | |
| – | -26.4% | +107.9% | +25.6% | +26.3% | +29.2% | +3.9% | +157.2% | -59.8% | +25.2% | +48.2% | +11.1% | |
| – | – | – | – | – | – | – | – | -81.8% | -82.3% | +667.7% | +148.0% | |
| – | – | +102.6% | +16.3% | +18.0% | +15.3% | +10.3% | -81.4% | +363.0% | -2.6% | +68.9% | +19.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +35.4% | -17.4% | -63.8% | -86.6% | +3,923.2% | -107.1% | – | -112.7% | – | +43.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.0% | +10.0% | +73.2% | +23.4% | +305.7% | +147.8% | +88.1% | +66.3% | +1,526.7% | +2,378.7% | +156.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.